You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

A generation ago, the market for vaccines worked well in wealthy countries – if you wanted to be immunized against a whole range of diseases, you could – but the system did not work that well for developing nations as they do not have the resources to make immunization available to everyone. With the COVID 19 pandemic the developed world has seen firsthand, the impact and disruption a virus, without a vaccine, can have on the economy, supply chain and day to day life. In developing countries, COVID is one more deadly virus add to the list of viruses they can’t afford to treat. Without low cost vaccines the impact to developing countries can be more devastating. Some of the leading causes of death in developing countries are HIV/AIDS, malaria and tuberculosis all can be solved thru affordable low cost immunization. The battle to lift the world’s poorest populations out of hunger, extreme poverty and disease is ongoing. In developed countries, low cost vaccines can help to ensure that all people, especially those people with the fewest resources, have access to the immunizations they need to survive. Speakers from the Bill and Melinda Gates Foundation, IPS-Integrated Project Services, LLC and Rommelag USA will discuss various programs, challenges and technologies to deploy low cost, distributed vaccine manufacturing capabilities in developing countries.

Presenters will provide an overview of the mission, grant program and several programs that the Gates Foundation is doing to reduce the cost of immunization and to give every person a chance at a healthy, productive life. Additionally, they will discuss the factors influencing the cost of vaccine manufacturing, COGS, and supply chain complexities in distributed vaccine manufacturing, including the utilization of aseptic blow/fill/seal technology.

This session will be moderated by Mark Butler and includes panelists Rachel Lee, Tim Kram, and Robert Roy.

Learn more about this engaging session on the 2022 ISPE Facilities of the Future Conference website.

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue

We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.